According to Smith & Nephew 's latest financial reports the company's current revenue (TTM) is $4.61 B. In 2013 the company made a revenue of $4.35 B an increase over the years 2012 revenue that were of $4.13 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2014 (TTM) | $4.61 B | 6.11% |
2013 | $4.35 B | 5.17% |
2012 | $4.13 B | -3.11% |
2011 | $4.27 B | 7.77% |
2010 | $3.96 B | 5.04% |
2009 | $3.77 B | -0.76% |
2008 | $3.80 B | 12.82% |
2007 | $3.36 B | 21.23% |
2006 | $2.77 B | 86.96% |
2005 | $1.48 B | -38.18% |
2004 | $2.40 B | 14.21% |
2003 | $2.10 B | 26.21% |
2002 | $1.66 B | 12.49% |
2001 | $1.48 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $89.65 B | 1,841.93% | ๐บ๐ธ USA |
Boston Scientific BSX | $14.70 B | 218.54% | ๐บ๐ธ USA |
Edwards Lifesciences EW | $6.14 B | 33.06% | ๐บ๐ธ USA |
Stryker Corporation SYK | $20.96 B | 354.04% | ๐บ๐ธ USA |
Orthofix Medical
OFIX | $0.74 B | -83.83% | ๐บ๐ธ USA |
CONMED CNMD | $1.26 B | -72.68% | ๐บ๐ธ USA |